Table 2.
TRAE, n | Navoximod 400 mg (N = 3) | Navoximod 600 mg (N = 4) | Navoximod 1000 mg (N = 3) | Total (N = 10) |
---|---|---|---|---|
Any, n | ||||
All grades | 1 | 2 | 3 | 6 |
Grade ≥ 3 | 1 | 1 | 0 | 2 |
Chromaturia, n | ||||
All grades | 0 | 2 | 3 | 5 |
Grade ≥ 3 | 0 | 0 | 0 | 0 |
Maculopapular rash, n | ||||
All grades | 1 | 0 | 1 | 2 |
Grade ≥ 3 | 1 | 0 | 0 | 1 |
TRAE treatment-related adverse event